Effect of Emotion-Focused Acceptance and Commitment Therapy on Obsessive-Compulsive Disorder Symptom Severity

ConditionsOCD Obsessive - Compulsive Disorder

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-65

SponsorMehmet Emrah Karadere

About this trial

This study aims to investigate the effect of Emotion-Focused Acceptance and Commitment Therapy (ACT) group psychotherapy on obsessive-compulsive disorder (OCD) symptom severity. Participants with OCD will be randomly assigned to either an ACT-based group psychotherapy arm or a supportive group psychotherapy arm. Each arm consists of 10 to 12 weekly sessions of 2 hours. Symptom severity, psychological flexibility, emotional awareness, functioning and quality of life will be assessed before and after the intervention.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of Obsessive-Compulsive Disorder according to DSM-5 criteria

Age between 18-65 years

Minimum literacy level

Willingness to participate and providing informed consent

Disqualifiers

Age over 65 years

Diagnosis of alcohol or substance use disorder

Comorbid psychotic disorder or intellectual disability

Any change in psychiatric treatment (medication or psychotherapy) in the last 3 months

Trial design

Design model

Parallel

Treatments tested in this trial

Emotion-Focused Acceptance and Commitment Therapy (ACT) Group Psychotherapy
Behavioral
Structured group psychotherapy based on ACT principles targeting emotional awareness, acceptance of emotional experiences, cognitive defusion, present-moment focus, values clarification and committed action. Sessions are conducted face-to-face, once weekly, 2 hours per session, for 10-12 weeks.

Treatment groups

36 Participants

are divided into 2 treatment groups

Group A: ACT-Based Group PsychotherapyExperimental treatment 1 intervention

Group B: Supportive Group PsychotherapyActive comparator 1 intervention

Trial outcomes

Primary outcomes

Obsessive-Compulsive Symptom Severity

Change in OCD symptom severity measured by Yale-Brown Obsessive Compulsive Scale (Y-BOCS) from baseline to post-treatment.

Time frame

Baseline and 10-12 weeks (post-treatment)

OCD Symtom Severity- DOCS

Change in OCD symptom severity measured by Dimensional Obsessive-Compulsive Scale (DOCS) from baseline to post treatment.

Time frame

Baseline and 10-12 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Mehmet Emrah Karadere

Lead sponsor

Goztepe Prof Dr Suleyman Yalcın City Hospital

Sponsor institution

Goztepe Prof Dr Suleyman Yalcın City Hospital

Collaborator

Source ClinicalTrials.gov

Apply now